<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21108" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Endometritis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Taylor</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>Wyckoff Heights Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jenkins</surname>
            <given-names>Suzanne M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pillarisetty</surname>
            <given-names>Leela Sharath</given-names>
          </name>
          <aff>Midland Memorial / Texas Tech University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Taylor declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Suzanne Jenkins declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leela Sharath Pillarisetty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21108.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Endometritis is an infectious inflammation of the endometrium that can cause severe long-term complications in women if not correctly diagnosed and treated. Diagnosing endometritis can be difficult and is frequently underdiagnosed due to its wide range of potential clinical features. Management requires accurate and prompt recognition of the conditions, appropriate antibiotics, and coordination between interdisciplinary professionals.</p>
        <p>This educational activity&#x000a0;addresses&#x000a0;various aspects of endometritis, including its classification into acute and chronic forms. It explores the clinical manifestations, diagnostic challenges, and implications, shedding light on the differences between endometritis and pelvic inflammatory disease. The&#x000a0;activity&#x000a0;emphasizes the vital role of the healthcare team in evaluating, diagnosing, and managing patients with endometritis, addressing both symptomatic presentations and asymptomatic cases that may contribute to conditions like recurrent pregnancy loss and infertility.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the clinical manifestations and risk factors associated with endometriosis, such as dysmenorrhea, chronic pelvic pain, and infertility.</p></list-item><list-item><p>Utilize appropriate diagnostic tools and assessments to screen for endometriosis in symptomatic patients.</p></list-item><list-item><p>Tailor treatment strategies to individual patient needs, considering factors like symptom severity, desire for fertility, and comorbid conditions.</p></list-item><list-item><p>Coordinate care and follow-up to ensure seamless coordination of care, referrals, and long-term follow-up to optimize patient outcomes and quality of life.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21108&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21108">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21108.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Endometritis is inflammation localized to the endometrium, the inner uterine lining, commonly due to an infectious etiology.<xref ref-type="bibr" rid="article-21108.r1">[1]</xref>&#x000a0;Infection that extends to the fallopian tubes, ovaries, or pelvic peritoneum is termed pelvic inflammatory disease (PID).<xref ref-type="bibr" rid="article-21108.r2">[2]</xref> Endometritis is traditionally classified into 2 types: acute and chronic. Postpartum endometritis is a subtype of acute endometritis associated with pregnancy.<xref ref-type="bibr" rid="article-21108.r3">[3]</xref><xref ref-type="bibr" rid="article-21108.r4">[4]</xref></p>
        <p>Acute endometritis unrelated to pregnancy refers to an endometrial infection present for &#x02264;30 days.<xref ref-type="bibr" rid="article-21108.r3">[3]</xref> It is typically due to a sexually transmitted infection (STI) or bacterial vaginosis (BV). Common symptoms are similar to those of PID (eg, fever, pelvic pain, vaginal discharge) and can range from mild to severe. Because of the overlapping symptoms, some clinicians consider acute endometritis to be synonymous with PID.<xref ref-type="bibr" rid="article-21108.r2">[2]</xref><xref ref-type="bibr" rid="article-21108.r3">[3]</xref><xref ref-type="bibr" rid="article-21108.r2">[2]</xref>&#x000a0;Histologically, it is characterized by the formation of microabscesses and neutrophilic invasion into the endometrium.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref>&#x000a0;Additionally, although acute salpingitis, which frequently accompanies acute endometritis in PID, is associated with tubal factor infertility due to scarring, acute endometritis alone is not associated with reduced fertility rates.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r6">[6]</xref></p>
        <p>Chronic endometritis is mild inflammation of the endometrium, typically due to microbial colonization not associated with pregnancy that lasts &#x02265;30 days.<xref ref-type="bibr" rid="article-21108.r3">[3]</xref> It&#x000a0;is characterized by plasma cells in the endometrial stroma and other signs of chronic inflammation. Patients are often asymptomatic; however, the most common presenting symptoms are abnormal uterine bleeding,&#x000a0;dyspareunia, and pelvic pain. Chronic endometritis is also frequently cited as contributing to recurrent pregnancy loss and infertility. The condition can be difficult to diagnose because, unlike acute endometritis, no defined diagnostic parameters other than endometrial stromal plasmacytes are considered sensitive histologic findings in most studies.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r7">[7]</xref><xref ref-type="bibr" rid="article-21108.r8">[8]</xref></p>
        <p>Postpartum endometritis is the most common cause of postpartum infection. Most cases of postpartum endometritis are polymicrobial, involving aerobic and anaerobic bacteria, and are due to the translocation of normal vaginal flora into the uterine cavity during labor and delivery.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref>&#x000a0;Endometritis&#x000a0;is 5 to 20 times more common in patients undergoing cesarean delivery than vaginal delivery.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref></p>
      </sec>
      <sec id="article-21108.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Endometritis primarily results from the ascension of microorganisms from the lower genital tract (ie, the cervix and vaginal vault) into the endometrial cavity. The specific pathogens more frequently found to infect the endometrium vary depending on the type of endometritis and are sometimes difficult to identify.<xref ref-type="bibr" rid="article-21108.r3">[3]</xref><xref ref-type="bibr" rid="article-21108.r4">[4]</xref></p>
        <p>
<bold>Acute Endometritis</bold>
</p>
        <p>In acute endometritis, &#x0003e;85% of infectious etiologies are caused by sexually transmitted infections (STIs). Unlike chronic and postpartum endometritis, which have multiple organisms linked to causation, the primary microbial etiology of acute endometritis is&#x000a0;<italic toggle="yes">Chlamydia trachomatis</italic>, followed by&#x000a0;<italic toggle="yes">Neisseria gonorrhoeae&#x000a0;</italic>and BV-associated bacteria.<xref ref-type="bibr" rid="article-21108.r3">[3]</xref><xref ref-type="bibr" rid="article-21108.r6">[6]</xref>&#x000a0;</p>
        <p>Risk factors for acute endometritis include age &#x0003c;25 years, a history of STIs, engaging in high-risk sexual behavior such as having multiple partners, and undergoing gynecologic procedures like placing intrauterine devices or endometrial biopsies. These factors contribute to the increased susceptibility to this condition among certain individuals.<xref ref-type="bibr" rid="article-21108.r9">[9]</xref><xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r6">[6]</xref></p>
        <p>
<bold>Chronic Endometritis</bold>
</p>
        <p>The etiology of chronic endometritis is often unknown. Some studies have shown possible endometrial inflammation associated with noninfectious etiologies (eg, intrauterine contraceptive devices, endometrial polyps, submucosal leiomyomas).<xref ref-type="bibr" rid="article-21108.r10">[10]</xref>&#x000a0;However, when a causative organism is identified, it is frequently a polymicrobial infection comprised of microorganisms commonly found in the vaginal vault. Additionally, genital tuberculosis can result in chronic granulomatous endometritis, most often seen in developing countries.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref>&#x000a0;Unlike&#x000a0;acute endometritis,&#x000a0;<italic toggle="yes">Chlamydia&#x000a0;trachomatis</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Neisseria gonorrhoeae&#x000a0;</italic>are not the most common etiologies.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref>&#x000a0;The primary causative organisms found include:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Streptococcus</italic> species</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Enterococcus&#x000a0;faecalis</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes"> Escherichia coli</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes"> Klebsiella&#x000a0;pneumoniae</italic>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Staphylococcus </italic>species</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Mycoplasma</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Ureaplasma</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Gardnerella&#x000a0;vaginalis</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Pseudomonas&#x000a0;aeruginosa</italic>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Saccharomyces cerevisiae</italic>&#x000a0;and <italic toggle="yes">candida</italic> species<xref ref-type="bibr" rid="article-21108.r11">[11]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>Chronic endometritis is associated with several risk factors, including the use of contraceptive intrauterine devices, a history of multiple pregnancies (multiparity), previous abortions, and experiencing abnormal uterine bleeding. These factors are important considerations in understanding the potential causes and contributors to chronic endometritis.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref></p>
        <p>
<bold>Postpartum Endometritis</bold>
</p>
        <p>During pregnancy, the amniotic membrane protects the uterine cavity from infection, and endometritis is uncommon. As the cervix dilates and the fetal membranes rupture, the opportunity for colonization of the uterine cavity by organisms from the vaginal vault increases. This risk is increased further with instrumentation and insertion of foreign bodies into the uterine cavity. Bacteria are also more likely to colonize uterine tissue that has been devitalized or otherwise damaged.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref><xref ref-type="bibr" rid="article-21108.r12">[12]</xref>&#x000a0;Similar to intraamniotic infections, postpartum endometrial infection is polymicrobial, involving both aerobic and anaerobic bacteria, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Gram-positive cocci: Groups A and B&#x000a0;S<italic toggle="yes">treptococci,&#x000a0;Staphylococcus,&#x000a0;Enterococcus</italic></p>
          </list-item>
          <list-item>
            <p>Gram-negative bacilli:&#x000a0;<italic toggle="yes">Escherichia coli,&#x000a0;Klebsiella pneumoniae, Proteus</italic></p>
          </list-item>
          <list-item>
            <p>Anaerobic organisms:&#x000a0;<italic toggle="yes">Bacteroides</italic>,&#x000a0;<italic toggle="yes">Peptostreptococcus</italic>,&#x000a0;<italic toggle="yes">Peptococcus,&#x000a0;</italic><italic toggle="yes">Prevotella</italic>, and&#x000a0;<italic toggle="yes">Clostridium</italic></p>
          </list-item>
          <list-item>
            <p>Others:<italic toggle="yes"> Mycoplasma, Neisseria gonorrhoeae</italic><xref ref-type="bibr" rid="article-21108.r3">[3]</xref><xref ref-type="bibr" rid="article-21108.r13">[13]</xref><xref ref-type="bibr" rid="article-21108.r14">[14]</xref></p>
          </list-item>
        </list>
        <p><italic toggle="yes">Chlamydia</italic>&#x000a0;<italic toggle="yes">trachomatis&#x000a0;</italic>is an uncommon cause of postpartum endometritis, though it is often associated with late-onset presentations.<xref ref-type="bibr" rid="article-21108.r15">[15]</xref>&#x000a0;Although rare, severe infections with <italic toggle="yes">Streptococcus pyogenes</italic>,&#x000a0;<italic toggle="yes">Staphylococcus aureus,&#x000a0;Clostridium sordellii</italic>, or <italic toggle="yes">Clostridium perfringens</italic> are associated with increased morbidity and mortality.<xref ref-type="bibr" rid="article-21108.r16">[16]</xref></p>
        <p>Postpartum endometritis is associated with a variety of risk factors, including cesarean delivery, intrapartum intraamniotic infection (known as chorioamnionitis), prolonged rupture of membranes or prolonged labor, the insertion of foreign bodies into the uterus (such as multiple cervical examinations and invasive uterine and fetal monitoring devices), manual extraction of the placenta, operative vaginal delivery, and certain maternal factors like HIV infection, diabetes mellitus, and obesity. Recognizing these risk factors is crucial in identifying and addressing postpartum endometritis, as they can contribute to the development of this condition and guide preventive measures and treatment strategies.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref><xref ref-type="bibr" rid="article-21108.r17">[17]</xref></p>
      </sec>
      <sec id="article-21108.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>
<bold>Acute Endometritis</bold>
</p>
        <p>The incidence of acute endometritis alone is challenging as it often occurs in the setting of PID, which has an incidence of approximately 8% in the United States (US) and 32% in developing countries.<xref ref-type="bibr" rid="article-21108.r18">[18]</xref> Cases of PID in the&#x000a0;US are frequently associated with <italic toggle="yes">Chlamydia trachomatis</italic> and <italic toggle="yes">Neisseria gonorrhoeae</italic> infections, accounting for 50% of such cases.<xref ref-type="bibr" rid="article-21108.r19">[19]</xref></p>
        <p>
<bold>Chronic Endometritis</bold>
</p>
        <p>Given the generally mild presentation, the true prevalence of chronic endometritis is difficult to estimate. In people with recurrent pregnancy loss, some studies have found the incidence estimated to be nearly 30%. However, the incidence varies, even in the same study, depending on which menstrual phase endometrial biopsies were performed.<xref ref-type="bibr" rid="article-21108.r7">[7]</xref><xref ref-type="bibr" rid="article-21108.r10">[10]</xref></p>
        <p>
<bold>Postpartum Endometritis</bold>
</p>
        <p>Postpartum endometritis is the leading cause of postpartum maternal fever.<xref ref-type="bibr" rid="article-21108.r20">[20]</xref> Its incidence ranges from 1% to 3% in patients without risk factors after a normal spontaneous vaginal delivery, increasing to about 5% to 6% with risk factors.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref> Cesarean delivery is a significant risk factor associated with a 5- to 20-fold increase in the risk of postpartum endometritis compared to spontaneous vaginal deliveries. If cesarean deliveries occur after the amniotic membrane rupture, the risk is even higher.<xref ref-type="bibr" rid="article-21108.r21">[21]</xref><xref ref-type="bibr" rid="article-21108.r22">[22]</xref><xref ref-type="bibr" rid="article-21108.r13">[13]</xref><xref ref-type="bibr" rid="article-21108.r14">[14]</xref> Appropriate antibiotic prophylaxis can reduce the risk of postpartum endometritis, with 20% of patients developing the condition without antibiotic prophylaxis.<xref ref-type="bibr" rid="article-21108.r13">[13]</xref>&#x000a0;Left untreated, postpartum endometritis can have a fatality rate estimated as high as 17%.<xref ref-type="bibr" rid="article-21108.r14">[14]</xref></p>
      </sec>
      <sec id="article-21108.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Acute endometritis is due to ascending infection from the cervix and vaginal vault, caused most often by&#x000a0;<italic toggle="yes">Chlamydia trachomatis</italic>. Endocervical infections disrupt the barrier functions of the endocervical canal, allowing the infection to ascend.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref></p>
        <p>Conversely, chronic endometritis is characterized by endometrial infection&#x000a0;by microorganisms not necessarily associated with concurrent cervical or vaginal colonization. The microbial infection leads to an immune response and chronic inflammation, with significant&#x000a0;infiltrates of endometrial stromal plasmacytes and the development of micropolyps.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r23">[23]</xref>&#x000a0;Elevations in interleukin-1b and tumor necrosis factor-alpha are also present, increasing estrogen synthesis in endometrial glandular cells. This increased estrogen synthesis may be associated with micropolyps, often seen on hysteroscopic evaluation in patients diagnosed with chronic endometritis.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref>&#x000a0;</p>
        <p>With postpartum endometritis, rupture of the amniotic membrane allows bacterial flora from the cervix and vagina to enter the endometrial lining.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref> This bacteria is more likely to colonize uterine tissue that has been devitalized, bleeding, or otherwise damaged (such as during a cesarean delivery). This bacteria can also invade the myometrium, causing inflammation and infection.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref></p>
      </sec>
      <sec id="article-21108.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Acute and chronic endometritis can be distinguished through histological characteristics. Acute endometritis is marked by microabscesses and the invasion of neutrophils into the superficial endometrial epithelium, glandular lumens, and the endometrial cavity.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref>&#x000a0;</p>
        <p>In contrast, chronic endometritis is identified by the infiltration of ESPCs, the presence of small polyps (micropolyps) measuring less than 1 mm, edematous changes during the proliferative phase, and out-of-phase morphology reflecting a mismatch in maturation between the stroma and epithelium.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r23">[23]</xref><xref ref-type="bibr" rid="article-21108.r7">[7]</xref> Additionally, B cells tend to accumulate in the endometrial stroma and glands of patients with chronic endometritis, although the exact significance of this observation remains uncertain.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r23">[23]</xref><xref ref-type="bibr" rid="article-21108.r7">[7]</xref></p>
      </sec>
      <sec id="article-21108.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical History</bold>
</p>
        <p>Acute and postpartum endometritis are clinically diagnosed based on characteristic symptoms and exam findings; chronic endometritis is often asymptomatic and typically requires histologic confirmation. Clinical histories and symptoms can overlap between the different types of endometritis and with differential diagnoses; however, some clinical features are associated more with&#x000a0;one type of endometritis than others. Therefore, a thorough history is essential to an accurate diagnosis. Clinicians obtaining a history should also attempt to identify common risk factors for PID (eg, multiple sex partners, history of STIs) and evidence of differential diagnoses through a comprehensive obstetrical and sexual history.<xref ref-type="bibr" rid="article-21108.r6">[6]</xref></p>
        <p>
<bold>Acute endometritis</bold>
</p>
        <p>Symptoms characteristic of acute endometritis are abrupt onset of pelvic pain, dyspareunia, and vaginal discharge, most commonly seen in sexually active individuals, although patients may be asymptomatic also.<xref ref-type="bibr" rid="article-21108.r6">[6]</xref><xref ref-type="bibr" rid="article-21108.r9">[9]</xref>&#x000a0;Depending on the severity of the disease, systemic symptoms, such as fever and malaise, may also be present, though they are frequently absent in milder cases. Additional symptoms include abnormal uterine bleeding (eg, postcoital, intermenstrual, or heavy menstrual bleeding), dyspareunia, and dysuria.<xref ref-type="bibr" rid="article-21108.r9">[9]</xref><xref ref-type="bibr" rid="article-21108.r24">[24]</xref>&#x000a0;Symptoms secondary to perihepatitis (ie, Fitz-Hugh-Curtis syndrome), tubo-ovarian abscess, or salpingitis can occur in patients with PID, including right upper quadrant pain and lower abdominal pain.<xref ref-type="bibr" rid="article-21108.r6">[6]</xref></p>
        <p>
<bold>Chronic endometritis</bold>
</p>
        <p>Patients with chronic endometritis often have histories of recurrent pregnancy loss, repeated implantation failure, and infertility.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r23">[23]</xref>&#x000a0;Chronic endometritis is often asymptomatic. If symptoms are present, they are typically nonspecific, with the most common complaints being abnormal uterine bleeding, pelvic discomfort, and leukorrhea.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref></p>
        <p>
<bold>Postpartum endometritis</bold>
</p>
        <p>A&#x000a0;key clinical feature of postpartum endometritis is fever following a recent delivery or miscarriage. Early-onset disease occurs within 48 hours postpartum, and late-onset disease refers to presentations up to 6 weeks postpartum.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref> Symptoms&#x000a0;that support this diagnosis include uterine tenderness, significant lower abdominal pain, purulent, foul-smelling lochia, and subinvolution of the uterus.<xref ref-type="bibr" rid="article-21108.r22">[22]</xref> Generalized symptoms such as malaise, headache, and chills may also be present.<xref ref-type="bibr" rid="article-21108.r22">[22]</xref>&#x000a0;</p>
        <p>
<bold>Clinical Examination</bold>
</p>
        <p>A focused abdominal and pelvic examination should be performed to assist in clinical diagnosis. A speculum examination to assess for evidence of infection is essential; vaginal discharge is a common finding of acute and chronic endometritis and should be sampled for diagnostic testing, while acute endometritis primarily presents with cervical motion tenderness and friability.<xref ref-type="bibr" rid="article-21108.r9">[9]</xref><xref ref-type="bibr" rid="article-21108.r24">[24]</xref> During the bimanual examination, uterine and adnexal tenderness to palpation is characteristic of acute endometritis; however, mild uterine discomfort on an exam may also be found with chronic endometritis.<xref ref-type="bibr" rid="article-21108.r3">[3]</xref></p>
        <p>Clinical&#x000a0;findings of postpartum endometritis include pronounced suprapubic and uterine tenderness, enlarged postpartum uterine size, and additional vital sign abnormalities such as fever and tachycardia.<xref ref-type="bibr" rid="article-21108.r1">[1]</xref><xref ref-type="bibr" rid="article-21108.r9">[9]</xref>&#x000a0;Maintaining a high index of suspicion for maternal sepsis is also important. In addition to fever and tachycardia, signs can include hypotension, hypothermia, altered mental status, and unexplained end-organ dysfunction.<xref ref-type="bibr" rid="article-21108.r25">[25]</xref>&#x000a0;Endometritis caused by Group A streptococcus or <italic toggle="yes">Clostridium</italic> species&#x000a0;is often particularly severe and can quickly develop into toxic shock syndrome and necrotizing fasciitis.</p>
      </sec>
      <sec id="article-21108.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Acute and postpartum endometritis are clinically diagnosed primarily based on history, physical exam, and risk factors. Imaging may be performed because of diagnostic uncertainty, persistent symptoms despite treatment, or differential diagnoses that cannot be excluded. The diagnosis of chronic endometritis typically relies on histologic examination or findings on hysteroscopy.<xref ref-type="bibr" rid="article-21108.r1">[1]</xref><xref ref-type="bibr" rid="article-21108.r8">[8]</xref></p>
        <p>
<bold>Acute Endometritis</bold>
</p>
        <p>Clinical features are very similar between acute endometritis and PID due to endometritis being a component of PID.&#x000a0;Because of the severe complications that may occur with undiagnosed PID, the Centers for Disease Control and Prevention (CDC) recommends presumptively diagnosing and treating patients with the minimum criteria of adnexal tenderness, uterine tenderness, or cervical motion tenderness with PID. Consequently, patients with isolated acute endometritis may be diagnosed with PID due to difficulty differentiating these conditions by symptoms alone.<xref ref-type="bibr" rid="article-21108.r6">[6]</xref><xref ref-type="bibr" rid="article-21108.r9">[9]</xref><xref ref-type="bibr" rid="article-21108.r3">[3]</xref>&#x000a0;</p>
        <p>Diagnostic laboratory studies should include testing for STIs and BV. The presence of&#x000a0;<italic toggle="yes">C</italic><italic toggle="yes">hlamydia trachomatis</italic>,&#x000a0;<italic toggle="yes">Neisseria gonorrhoeae, </italic>or&#x000a0;<italic toggle="yes">Mycoplasma genitalium</italic><italic toggle="yes">&#x000a0;</italic>is best assessed&#x000a0;with nucleic acid amplification tests on endocervical specimens;&#x000a0;<italic toggle="yes">Trichomas vaginalis</italic> and BV can be diagnosed on microscopic evaluation of vaginal discharge using a wet prep. In areas where microscopy is unavailable, commercially available molecular tests may be used.<xref ref-type="bibr" rid="article-21108.r9">[9]</xref><xref ref-type="bibr" rid="article-21108.r3">[3]</xref>&#x000a0;Additionally, it is recommended that patients suspected of having PID should be screened for HIV and syphilis due to similarities in risk factors and the frequency of concurrent infections.<xref ref-type="bibr" rid="article-21108.r9">[9]</xref>&#x000a0;An endometrial biopsy is generally not indicated.<xref ref-type="bibr" rid="article-21108.r9">[9]</xref><xref ref-type="bibr" rid="article-21108.r6">[6]</xref>&#x000a0;Other laboratory studies that may be used to support a diagnosis of acute endometritis or PID are erythrocyte sedimentation rate and C-reactive protein, which are often elevated but are nonspecific findings. Leukocytosis is common, but white blood cell count may be normal in milder cases.<xref ref-type="bibr" rid="article-21108.r9">[9]</xref><xref ref-type="bibr" rid="article-21108.r6">[6]</xref>&#x000a0;</p>
        <p>Imaging with transvaginal ultrasonography should be considered when patients fail to respond to appropriate antibiotic therapy or to rule out other diagnoses in patients with moderate to severe symptoms. Pelvic CT or MRI&#x000a0;may help rule out other causes of the patient's symptoms in complex cases.<xref ref-type="bibr" rid="article-21108.r9">[9]</xref><xref ref-type="bibr" rid="article-21108.r6">[6]</xref></p>
        <p>
<bold>Chronic Endometritis</bold>
</p>
        <p>Chronic endometritis is frequently asymptomatic and has nonspecific diagnostic serum and culture results. Therefore, diagnosis typically requires histologic or hysteroscopic confirmation. An endometrial biopsy sample can be obtained and assessed for the presence&#x000a0;of multiple endometrial stromal plasmacytes (ESPCs), either by traditional tissue staining techniques or using immunohistochemistry marker CD138.&#x000a0;However, experts have no consensus on how many ESPCs are considered diagnostic.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r23">[23]</xref><xref ref-type="bibr" rid="article-21108.r7">[7]</xref></p>
        <p>Therefore, the International Working Group for Standardization of Chronic Endometritis Diagnosis developed criteria for the definitive diagnosis of chronic endometritis. According to their criteria, a histological diagnosis could be made if 1 to 5 endometrial stromal plasmacytes (ESPCs)/high-power field or discrete clusters of &#x0003c;20 ESPCs by CD138 staining.<xref ref-type="bibr" rid="article-21108.r8">[8]</xref>&#x000a0;Moreover, the following hysteroscopic findings obtained during the follicular phase of the menstrual cycle were defined as being diagnostic for chronic endometritis:</p>
        <list list-type="bullet">
          <list-item>
            <p>Endometrial micro polyposis (ie, 1-2 mm protrusions from the endometrial surface)</p>
          </list-item>
          <list-item>
            <p>Stromal edema causing a thick, pale appearance of the endometrium in the follicular phase instead of the secretory phase, as is usually seen</p>
          </list-item>
          <list-item>
            <p>Focal-reddened areas of the endometrium with sharp and irregular borders</p>
          </list-item>
          <list-item>
            <p>Large regions of hyperemic endometrium flushed with white central points</p>
          </list-item>
          <list-item>
            <p>Focal hyperemia<xref ref-type="bibr" rid="article-21108.r8">[8]</xref><xref ref-type="bibr" rid="article-21108.r7">[7]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Postpartum Endometritis</bold>
</p>
        <p>Postpartum endometritis is also primarily a clinical diagnosis in any postpartum patient with unexplained fever. Early-onset postpartum endometritis is defined as the onset of symptoms within 48 hours of delivery; late-onset postpartum endometritis has symptom onset within 6 weeks of delivery.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref>&#x000a0;Laboratory studies help exclude differential diagnoses or monitor for progressive infection (eg, sepsis). Serum laboratory studies can support a diagnosis but do not confirm endometritis. Endocervical cultures, when negative, do not exclude an endometrial infection, and positive cultures may result from contamination from the vaginal vault during collection.<xref ref-type="bibr" rid="article-21108.r4">[4]</xref><xref ref-type="bibr" rid="article-21108.r26">[26]</xref></p>
        <p>Leukocytosis is a normal finding immediately postpartum, especially in those who underwent cesarean delivery. However, leukocytosis of 15,000 to 30,000 cells/&#x003bc;L is often present in cases of peripartum chorioamnionitis and postpartum endometritis, and a complete blood count with differential should be ordered during evaluation.<xref ref-type="bibr" rid="article-21108.r27">[27]</xref> An increasing left shift (ie, bandemia &#x0003e;10%) is also suggestive of infection. A urinalysis and culture should also be obtained to rule out urinary tract infections (UTIs), which can have similar symptomatology.<xref ref-type="bibr" rid="article-21108.r25">[25]</xref>&#x000a0;Cervical and endometrial cultures are generally not indicated, as they rarely change management. They may be helpful, however, if group A streptococcus or an STI is suspected.<xref ref-type="bibr" rid="article-21108.r22">[22]</xref> Blood cultures, serum lactate, comprehensive metabolic panel, coagulation panel, and surgical site cultures should be obtained if patients have findings suspicious&#x000a0;for sepsis (eg, fever &#x0003e;102 &#x000b0;F [38.9 &#x000b0;C], tachycardia, tachypnea, or hypotension).<xref ref-type="bibr" rid="article-21108.r25">[25]</xref></p>
        <p>In most cases, pelvic ultrasound is recommended as the first-line modality if imaging is performed. However, imaging is rarely helpful unless an alternative diagnosis (eg, retained products of conception or septic pelvic thrombophlebitis) is suspected. Imaging findings in postpartum endometritis are generally nonspecific, and there is a significant overlap with normal postpartum findings (eg, minimal amounts of gas in the endometrial cavity, enlarged uterus); therefore, any findings should be correlated to clinical history. A pelvic CT may also be considered in some suspected conditions (eg, pelvic abscess or&#x000a0;septic pelvic thrombophlebitis).<xref ref-type="bibr" rid="article-21108.r1">[1]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-21108.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Acute Endometritis</bold>
</p>
        <p>The CDC recommends several different antibiotic regimens.<xref ref-type="bibr" rid="article-21108.r28">[28]</xref><xref ref-type="bibr" rid="article-21108.r29">[29]</xref>&#x000a0;The following oral regimens are recommended for mild to moderate cases that can be managed as an outpatient.</p>
        <list list-type="bullet">
          <list-item>
            <p>Option 1:
<list list-type="bullet"><list-item><p>Ceftriaxone 500 mg intramuscularly&#x000a0;one time</p></list-item><list-item><p>+ doxycycline 100 mg orally twice daily for 14 days&#x000a0;</p></list-item><list-item><p>+ metronidazole 500 mg orally twice daily for 14 days<xref ref-type="bibr" rid="article-21108.r28">[28]</xref><xref ref-type="bibr" rid="article-21108.r29">[29]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Option 2:
<list list-type="bullet"><list-item><p>Cefoxitin 2 g intramuscularly once&#x000a0;<italic toggle="yes">with&#x000a0;</italic>probenecid 1 g orally once&#x000a0;</p></list-item><list-item><p>+&#x000a0;doxycycline 100 mg orally twice daily for 14 days&#x000a0;</p></list-item><list-item><p>+ metronidazole 500 mg orally twice daily for 14 days<xref ref-type="bibr" rid="article-21108.r28">[28]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Option 3:
<list list-type="bullet"><list-item><p>Other parenteral third-generation cephalosporins (eg, ceftizoxime or cefotaxime)&#x000a0;</p></list-item><list-item><p>+&#x000a0;doxycycline 100 mg orally twice daily for 14 days&#x000a0;</p></list-item><list-item><p>+&#x000a0;metronidazole 500 mg orally twice daily for 14 days<xref ref-type="bibr" rid="article-21108.r28">[28]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Alternative regimens for patients with severe cephalosporin allergies include:
<list list-type="bullet"><list-item><p>Levofloxacin 500 mg orally once daily <italic toggle="yes">or&#x000a0;</italic>moxifloxacin 400 mg orally once daily&#x000a0;(preferred for <italic toggle="yes">M.&#x000a0;genitalium</italic>&#x000a0;infections) for 14 days&#x000a0;</p></list-item><list-item><p>+&#x000a0;metronidazole 500 mg every 8 hours&#x000a0;for 14 days&#x000a0;</p></list-item><list-item><p>Azithromycin 500 mg intravenously once daily for 1 to 2 doses, followed by 250 mg orally daily&#x000a0;+<bold>&#x000a0;</bold>metronidazole 500 mg orally twice daily for 12 to 14 days<xref ref-type="bibr" rid="article-21108.r28">[28]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Indications for inpatient hospitalization include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Tubo-ovarian abscess</p>
          </list-item>
          <list-item>
            <p>Failure of outpatient therapy or inability to follow or tolerate the outpatient regimen</p>
          </list-item>
          <list-item>
            <p>Severe illness, nausea, vomiting, or oral temperature &#x0003e;101 &#x000b0;F (38.5 &#x000b0;C)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Surgical emergencies (eg, appendicitis) cannot be excluded<xref ref-type="bibr" rid="article-21108.r28">[28]</xref></p>
          </list-item>
        </list>
        <p>Inpatient parenteral antibiotics until patients show signs of clinical improvement (eg, decreasing fever and abdominal tenderness), typically within 24 to 48 hours, after which they can be transitioned to an oral regimen. Recommended parental regimens include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cefoxitin 2 g&#x000a0;intravenously every 6 hours&#x000a0;<italic toggle="yes">or&#x000a0;</italic>cefotetan 2 g&#x000a0;intravenously every 12 hours</p>
          </list-item>
          <list-item>
            <p>+&#x000a0;Doxycycline 100 mg orally or&#x000a0;intravenously every 12 hours<xref ref-type="bibr" rid="article-21108.r28">[28]</xref></p>
          </list-item>
        </list>
        <p>Alternative parenteral regimens:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ampicillin-sulbactam 3 g intravenously every 6 hours +&#x000a0;doxycycline 100 mg orally or intravenously every 12 hours</p>
          </list-item>
          <list-item>
            <p>Clindamycin 900 mg&#x000a0;intravenously every 8 hours +&#x000a0;gentamicin intravenously or intramuscularly 3 to 5 mg/kg every 24 hours</p>
          </list-item>
        </list>
        <p>
<bold>Chronic Endometritis</bold>
</p>
        <p>Chronic endometritis is typically treated with doxycycline 100 mg orally twice daily for 14 days.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref>&#x000a0;For patients who fail doxycycline therapy, metronidazole 500 mg orally daily for 14 days plus ciprofloxacin 400 mg orally daily for 14 days can be used.</p>
        <p>For chronic granulomatous endometritis, antitubercular therapy is recommended, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Isoniazid 300 mg per day</p>
          </list-item>
          <list-item>
            <p>+<bold>&#x000a0;</bold>rifampicin 450 to 600 mg per day</p>
          </list-item>
          <list-item>
            <p>+&#x000a0;ethambutol 800 to 1200 mg per day</p>
          </list-item>
          <list-item>
            <p>+&#x000a0;pyrazinamide 1200 to 1500 mg per day<xref ref-type="bibr" rid="article-21108.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Postpartum Endometritis</bold>
</p>
        <p>Most patients should be treated with intravenous antibiotics, including those with moderate to severe disease, concern for sepsis, or endometritis after cesarean delivery. A Cochrane review on antibiotic regimens for postpartum endometritis identified the following clindamycin plus gentamicin regimen as the most effective:<xref ref-type="bibr" rid="article-21108.r4">[4]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Gentamicin 5 mg/kg&#x000a0;intravenous every 24 hours (preferred) or 1.5 mg/kg&#x000a0;intravenous every 8 hours or +<bold>&#x000a0;</bold>clindamycin 900 mg&#x000a0;intravenous every 8 hours&#x000a0;</p>
          </list-item>
          <list-item>
            <p>If group B <italic toggle="yes">Streptococcus</italic>-positive or signs and symptoms fail to improve within 48 hours,&#x000a0;<italic toggle="yes">add&#x000a0;</italic>any&#x000a0;of the following:
<list list-type="bullet"><list-item><p>Ampicillin 2 g&#x000a0;intravenous every 6 hours or</p></list-item><list-item><p>Ampicillin 2 g&#x000a0;intravenous loading dose, followed by 1 g every 4 to 8 hours</p></list-item><list-item><p>Ampicillin-sulbactam 3 g&#x000a0;intravenous every 6 hours<xref ref-type="bibr" rid="article-21108.r25">[25]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>For&#x000a0;those that do not&#x000a0;improve within 72 hours, providers should broaden their differential diagnosis to include other infections such as pneumonia, pyelonephritis, and pelvic septic thrombophlebitis. Intravenous antibiotics should be continued until the patient remains afebrile for at least 24 hours, alongside improved pain reduction and resolution of leukocytosis. No substantial evidence demonstrates that continuing antibiotics in oral form following clinical improvement improves significant patient-oriented outcomes.<xref ref-type="bibr" rid="article-21108.r30">[30]</xref><xref ref-type="bibr" rid="article-21108.r4">[4]</xref>&#x000a0;An oral antibiotic regimen may be carefully considered in&#x000a0;patients with mild symptoms that are identified after discharge from the hospital (ie, late-onset postpartum endometritis).<xref ref-type="bibr" rid="article-21108.r15">[15]</xref></p>
      </sec>
      <sec id="article-21108.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>In addition to acute endometritis, the differential diagnosis of pelvic pain includes ectopic pregnancy, hemorrhagic or ruptured ovarian cyst, ovarian torsion, endometriosis, tubo-ovarian abscess, acute cystitis, renal stones, and gastrointestinal causes (eg, appendicitis, diverticulitis, irritable bowel syndrome).<xref ref-type="bibr" rid="article-21108.r26">[26]</xref></p>
        <p>Frequent presenting symptoms of chronic endometritis frequently are abnormal uterine bleeding (AUB) or fertility challenges. The differential diagnosis of irregular bleeding is broad. The American College of Obstetricians and Gynecologists (ACOG) recommends classifying AUB according to the PALM-COEIN system, which is an acronym standing for polyps, adenomyosis, leiomyomas, malignancy, coagulopathy, ovulatory dysfunction, endometrial causes (eg, acute or chronic endometritis), iatrogenic (eg, anticoagulant medication, hormonal contraceptives), and not-yet-classified.<xref ref-type="bibr" rid="article-21108.r31">[31]</xref>&#x000a0;Infertility also has a broad differential that includes uterine factors, tubal factors, ovulatory or hormonal dysfunction, chromosomal issues, and male factor etiologies.<xref ref-type="bibr" rid="article-21108.r32">[32]</xref></p>
        <p>In patients with postpartum fever, differential diagnoses include surgical site infections, UTIs, pyelonephritis, mastitis, pneumonia, sepsis, peritonitis, and septic pelvic thrombophlebitis.<xref ref-type="bibr" rid="article-21108.r15">[15]</xref><xref ref-type="bibr" rid="article-21108.r1">[1]</xref></p>
      </sec>
      <sec id="article-21108.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>If untreated, the fatality rate of postpartum endometritis is approximately 17%.<xref ref-type="bibr" rid="article-21108.r14">[14]</xref>&#x000a0;In well-developed countries, however, the prognosis is typically excellent with appropriate treatment.&#x000a0;Acute endometritis alone has an excellent prognosis; however, it is frequently present with salpingitis, significantly increasing the risk for tubal factor infertility.<xref ref-type="bibr" rid="article-21108.r5">[5]</xref><xref ref-type="bibr" rid="article-21108.r6">[6]</xref>&#x000a0;Evidence suggests that fertility outcomes can improve significantly after treatment for chronic endometritis. For example, in a study looking at fresh day 3 embryo transfer cycles, live birth rates were significantly higher in treated versus untreated patients, approximately 60% to 65% versus 6% to 15%, respectively.<xref ref-type="bibr" rid="article-21108.r11">[11]</xref> Another study demonstrated that in patients with recurrent pregnancy loss and chronic endometritis, live birth rates increased from 7% before treatment to 56% after treatment.<xref ref-type="bibr" rid="article-21108.r33">[33]</xref></p>
      </sec>
      <sec id="article-21108.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Acute endometritis, particularly PID-associated, may lead to infertility,&#x000a0;chronic pelvic pain, and ectopic pregnancy. Additionally, the ascending infection may develop into a tubo-ovarian abscess.<xref ref-type="bibr" rid="article-21108.r26">[26]</xref>&#x000a0;Complications of chronic endometritis include&#x000a0;fertility issues (eg, recurrent pregnancy loss and repeated implantation failure) and AUB.<xref ref-type="bibr" rid="article-21108.r7">[7]</xref>&#x000a0;Approximately 1% to 4% of patients with postpartum endometritis can have complications such as sepsis, abscesses, hematomas, septic pelvic thrombophlebitis, and necrotizing fasciitis. Surgical intervention may be necessary if the infection has produced a drainable fluid collection.<xref ref-type="bibr" rid="article-21108.r22">[22]</xref></p>
      </sec>
      <sec id="article-21108.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients diagnosed with postpartum endometritis should be managed by clinicians experienced in treating this condition. Consultation with an obstetrician is indicated for patients presenting to emergency departments, urgent care clinics, and primary care providers who do not practice obstetrics. Patients needing specialized evaluation and management of AUB or pelvic pain or requiring surgical evaluation may also require&#x000a0;obstetrician and gynecologist specialist services.<xref ref-type="bibr" rid="article-21108.r26">[26]</xref><xref ref-type="bibr" rid="article-21108.r34">[34]</xref>&#x000a0;Patients with infertility issues should be referred to a reproductive endocrinologist/infertility specialist.</p>
      </sec>
      <sec id="article-21108.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Due to the significant increase in prevalence and mortality of endometritis after cesarean deliveries, ACOG&#x000a0;recommends prophylactic antibiotics before all cesarean deliveries.&#x000a0;A recent Cochrane review showed a significant reduction in the risk of postpartum infections, including endometritis, when&#x000a0;appropriate&#x000a0;antibiotics were given.&#x000a0;The regimen recommended in the ACOG Practice Bulletin on prophylactic antibiotics in labor and delivery recommends giving a first-generation cephalosporin, such as cefazolin 1 g intravenously once, administered within 1 hour before skin incision.<xref ref-type="bibr" rid="article-21108.r35">[35]</xref> Additionally, evidence demonstrates improved outcomes in patients undergoing cesarean deliveries after being in labor who received azithromycin 500 mg IV infused over 1 hour <italic toggle="yes">in addition to</italic> standard preoperative prophylaxis (ie, cefazolin). The increased risk of postpartum infection should be discussed with patients before cesarean delivery as part of the informed consent process.<xref ref-type="bibr" rid="article-21108.r35">[35]</xref>&#x000a0;</p>
        <p>Outside of pregnancy, recommended endometritis and PID prevention strategies include treatment of symptomatic BV, appropriate screening for STIs in all women younger than 25 years or those 25 years or older who are&#x000a0;at increased risk for STIs (eg,&#x000a0;a new sex partner, more than one sex partner, a sex partner with concurrent partners, or a sex partner who has an STI), and providing behavioral counseling for all adolescents and adults at increased risk of sexually transmitted infections.<xref ref-type="bibr" rid="article-21108.r3">[3]</xref><xref ref-type="bibr" rid="article-21108.r26">[26]</xref></p>
      </sec>
      <sec id="article-21108.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Endometritis is inflammation of the uterine endometrium.</p>
          </list-item>
          <list-item>
            <p>Postpartum endometritis is the most common postpartum infection and&#x000a0;should be suspected in any postpartum patient with unexplained fever. Purulent or foul-smelling lochia supports the diagnosis.&#x000a0;Early diagnosis and obstetric consultation are essential.</p>
          </list-item>
          <list-item>
            <p>Acute endometritis is considered part of PID, often coexisting with salpingitis and cervicitis. Isolated acute endometritis and PID are difficult to differentiate, but as treatment is the same, distinguishing one from the other is unnecessary for management.</p>
          </list-item>
          <list-item>
            <p>Chronic endometritis is associated with recurrent pregnancy loss, repeated implantation failure, and infertility.</p>
          </list-item>
          <list-item>
            <p>Treatment in all types of endometritis is with appropriate antibiotics.</p>
          </list-item>
          <list-item>
            <p>The severity of endometritis can vary; if necessary, resuscitation, including early antibiotic administration, should be the primary focus.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21108.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Postpartum endometritis is the most common cause of postpartum fever. Nurses are frequently the first clinicians to identify signs and symptoms of endometritis in their postpartum patients on the floor. Recognizing the clinical significance of fever in postpartum patients warrants prompt notification of the primary obstetrician. Disease severity can range from mild to severe, with most patients requiring intravenous antibiotics. Left untreated, mortality rates are high, so prompt initiation of appropriate antibiotics is crucial in improving outcomes. This requires proper communication and coordination between nursing, physicians, and pharmacy staff; with appropriate&#x000a0;interprofessional collaboration, patient outcomes are excellent.</p>
        <p>Patients with acute and chronic endometritis often present to nonobstetric primary care clinicians, urgent care centers, and emergency departments. Early obstetric consultation is critical for efficient and appropriate diagnosis and treatment. If imaging is needed, ultrasonographers, radiology technicians, and diagnostic radiologists are all crucial in arriving at an accurate diagnosis. For ideal antibiotic selection, dosing, and administration, a clinical pharmacist may help validate antimicrobial therapy with the latest antibiogram data, check for medication interactions, and alert other health team members to potential adverse effects. An anesthesiologist is also necessary for a successful surgery if operative intervention is required.</p>
      </sec>
      <sec id="article-21108.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21108&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21108">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/endometritis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21108">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21108/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21108">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21108.s18">
        <title>References</title>
        <ref id="article-21108.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzalo-Carballes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>R&#x000ed;os-Vives</surname>
                <given-names>M&#x000c1;</given-names>
              </name>
              <name>
                <surname>Fierro</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Azogue</surname>
                <given-names>XG</given-names>
              </name>
              <name>
                <surname>Herrero</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Rus</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Planes-Conangla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Escudero-Fernandez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Coscojuela</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A Pictorial Review of Postpartum Complications.</article-title>
            <source>Radiographics</source>
            <year>2020</year>
            <season>Nov-Dec</season>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>2117</fpage>
            <page-range>2117-2141</page-range>
            <pub-id pub-id-type="pmid">33095681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soper</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Wiesenfeld</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>The Continued Challenges in the Diagnosis of Acute Pelvic Inflammatory Disease: Focus on Clinically Mild Disease.</article-title>
            <source>J Infect Dis</source>
            <year>2021</year>
            <month>Aug</month>
            <day>16</day>
            <volume>224</volume>
            <issue>12 Suppl 2</issue>
            <fpage>S75</fpage>
            <page-range>S75-S79</page-range>
            <pub-id pub-id-type="pmid">34396404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ravel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sim&#x000f3;n</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>224</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-257</page-range>
            <pub-id pub-id-type="pmid">33091407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mackeen</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Packard</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Ota</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Speer</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic regimens for postpartum endometritis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Feb</month>
            <day>02</day>
            <volume>2015</volume>
            <issue>2</issue>
            <fpage>CD001067</fpage>
            <pub-id pub-id-type="pmid">25922861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitaya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mizuta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matsubayashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Endometritis: new time, new concepts.</article-title>
            <source>Fertil Steril</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>344</fpage>
            <page-range>344-350</page-range>
            <pub-id pub-id-type="pmid">29960704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gradison</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pelvic inflammatory disease.</article-title>
            <source>Am Fam Physician</source>
            <year>2012</year>
            <month>Apr</month>
            <day>15</day>
            <volume>85</volume>
            <issue>8</issue>
            <fpage>791</fpage>
            <page-range>791-6</page-range>
            <pub-id pub-id-type="pmid">22534388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pirtea</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cicinelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>De Nola</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Ziegler</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ayoubi</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis.</article-title>
            <source>Fertil Steril</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>115</volume>
            <issue>3</issue>
            <fpage>546</fpage>
            <page-range>546-560</page-range>
            <pub-id pub-id-type="pmid">33581856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cicinelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vitagliano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lasmar</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Bettocchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haimovich</surname>
                <given-names>S</given-names>
              </name>
              <collab>International Working Group for Standardization of Chronic Endometritis Diagnosis</collab>
            </person-group>
            <article-title>Unified diagnostic criteria for chronic endometritis at fluid hysteroscopy: proposal and reliability evaluation through an international randomized-controlled observer study.</article-title>
            <source>Fertil Steril</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>112</volume>
            <issue>1</issue>
            <fpage>162</fpage>
            <page-range>162-173.e2</page-range>
            <pub-id pub-id-type="pmid">31104760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ross</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guaschino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cusini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>2017 European guideline for the management of pelvic inflammatory disease.</article-title>
            <source>Int J STD AIDS</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>108</fpage>
            <page-range>108-114</page-range>
            <pub-id pub-id-type="pmid">29198181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and confounders of chronic endometritis in premenopausal women with abnormal bleeding or reproductive failure.</article-title>
            <source>Reprod Biomed Online</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>78</fpage>
            <page-range>78-83</page-range>
            <pub-id pub-id-type="pmid">29111313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cicinelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Matteo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Trojano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mitola</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Tinelli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vitagliano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Crupano</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Lepera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miragliotta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Resta</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Chronic endometritis in patients with unexplained infertility: Prevalence and effects of antibiotic treatment on spontaneous conception.</article-title>
            <source>Am J Reprod Immunol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>79</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29135053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <article-title>Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>e95</fpage>
            <page-range>e95-e101</page-range>
            <pub-id pub-id-type="pmid">28742677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smaill</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Grivell</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Oct</month>
            <day>28</day>
            <volume>2014</volume>
            <issue>10</issue>
            <fpage>CD007482</fpage>
            <pub-id pub-id-type="pmid">25350672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meaney-Delman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Gravett</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Oral and intramuscular treatment options for early postpartum endometritis in low-resource settings: a systematic review.</article-title>
            <source>Obstet Gynecol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>125</volume>
            <issue>4</issue>
            <fpage>789</fpage>
            <page-range>789-800</page-range>
            <pub-id pub-id-type="pmid">25751198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalton</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Post partum infections: A review for the non-OBGYN.</article-title>
            <source>Obstet Med</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>98</fpage>
            <page-range>98-102</page-range>
            <pub-id pub-id-type="pmid">27512432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donders</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Greenhouse</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Donders</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Paavonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mendling</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Genital Tract GAS Infection ISIDOG Guidelines.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>May</month>
            <day>10</day>
            <volume>10</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">34068785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <article-title>Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782.</article-title>
            <source>Obstet Gynecol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>134</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">31241599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haggerty</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Ness</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of pelvic inflammatory disease.</article-title>
            <source>Womens Health (Lond)</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>383</fpage>
            <page-range>383-97</page-range>
            <pub-id pub-id-type="pmid">19072503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kreisel</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Llata</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Haderxhanaj</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wiesenfeld</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Torrone</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>The Burden of and Trends in Pelvic Inflammatory Disease in the United States, 2006-2016.</article-title>
            <source>J Infect Dis</source>
            <year>2021</year>
            <month>Aug</month>
            <day>16</day>
            <volume>224</volume>
            <issue>12 Suppl 2</issue>
            <fpage>S103</fpage>
            <page-range>S103-S112</page-range>
            <pub-id pub-id-type="pmid">34396411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaim</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bashiri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bar-David</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shoham-Vardi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mazor</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and clinical significance of postpartum endometritis and wound infection.</article-title>
            <source>Infect Dis Obstet Gynecol</source>
            <year>2000</year>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-82</page-range>
            <pub-id pub-id-type="pmid">10805361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boggess</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Tita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jauk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Saade</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>EAS</given-names>
              </name>
              <name>
                <surname>Esplin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cleary</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wapner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Letson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blackwell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beamon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Szychowski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>W</given-names>
              </name>
              <collab>Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium</collab>
            </person-group>
            <article-title>Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>481</fpage>
            <page-range>481-485</page-range>
            <pub-id pub-id-type="pmid">28178058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karsnitz</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Puerperal infections of the genital tract: a clinical review.</article-title>
            <source>J Midwifery Womens Health</source>
            <year>2013</year>
            <season>Nov-Dec</season>
            <volume>58</volume>
            <issue>6</issue>
            <fpage>632</fpage>
            <page-range>632-42</page-range>
            <pub-id pub-id-type="pmid">24406036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitaya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Chronic endometritis: simple can be harder than complex?</article-title>
            <source>Fertil Steril</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>115</volume>
            <issue>6</issue>
            <fpage>1443</fpage>
            <page-range>1443-1444</page-range>
            <pub-id pub-id-type="pmid">33892957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soper</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Pelvic inflammatory disease.</article-title>
            <source>Obstet Gynecol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>116</volume>
            <issue>2 Pt 1</issue>
            <fpage>419</fpage>
            <page-range>419-428</page-range>
            <pub-id pub-id-type="pmid">20664404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Assis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Halscott</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Top 10 Pearls for the Recognition, Evaluation, and Management of Maternal Sepsis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2021</year>
            <month>Aug</month>
            <day>01</day>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>289</fpage>
            <page-range>289-304</page-range>
            <pub-id pub-id-type="pmid">34237760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Curry</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Penny</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Sep</month>
            <day>15</day>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>357</fpage>
            <page-range>357-364</page-range>
            <pub-id pub-id-type="pmid">31524362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conde-Agudelo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Garcia S&#x000e1;nchez</surname>
                <given-names>&#x000c1;J</given-names>
              </name>
            </person-group>
            <article-title>Management of clinical chorioamnionitis: an evidence-based approach.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>223</volume>
            <issue>6</issue>
            <fpage>848</fpage>
            <page-range>848-869</page-range>
            <pub-id pub-id-type="pmid">33007269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hazra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Collison</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>CDC Sexually Transmitted Infections Treatment Guidelines, 2021.</article-title>
            <source>JAMA</source>
            <year>2022</year>
            <month>Mar</month>
            <day>01</day>
            <volume>327</volume>
            <issue>9</issue>
            <fpage>870</fpage>
            <page-range>870-871</page-range>
            <pub-id pub-id-type="pmid">35230409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalby</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stoner</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Sexually Transmitted Infections: Updates From the 2021 CDC Guidelines.</article-title>
            <source>Am Fam Physician</source>
            <year>2022</year>
            <month>May</month>
            <day>01</day>
            <volume>105</volume>
            <issue>5</issue>
            <fpage>514</fpage>
            <page-range>514-520</page-range>
            <pub-id pub-id-type="pmid">35559639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeNoble</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Kuller</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Heine</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Dotters-Katz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics for the Prevention and Treatment of Postsurgical Obstetric Infections.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>73</volume>
            <issue>8</issue>
            <fpage>475</fpage>
            <page-range>475-485</page-range>
            <pub-id pub-id-type="pmid">30169886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <collab>Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women.</article-title>
            <source>Obstet Gynecol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>120</volume>
            <issue>1</issue>
            <fpage>197</fpage>
            <page-range>197-206</page-range>
            <pub-id pub-id-type="pmid">22914421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <article-title>Infertility Workup for the Women's Health Specialist: ACOG Committee Opinion, Number 781.</article-title>
            <source>Obstet Gynecol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>133</volume>
            <issue>6</issue>
            <fpage>e377</fpage>
            <page-range>e377-e384</page-range>
            <pub-id pub-id-type="pmid">31135764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McQueen</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Perfetto</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Hazard</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Lathi</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss.</article-title>
            <source>Fertil Steril</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>104</volume>
            <issue>4</issue>
            <fpage>927</fpage>
            <page-range>927-931</page-range>
            <pub-id pub-id-type="pmid">26207958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wouk</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Helton</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Abnormal Uterine Bleeding in Premenopausal Women.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Apr</month>
            <day>01</day>
            <volume>99</volume>
            <issue>7</issue>
            <fpage>435</fpage>
            <page-range>435-443</page-range>
            <pub-id pub-id-type="pmid">30932448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21108.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <collab>Committee on Practice Bulletins-Obstetrics</collab>
            <article-title>ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>3</issue>
            <fpage>e103</fpage>
            <page-range>e103-e119</page-range>
            <pub-id pub-id-type="pmid">30134425</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
